03 Profile
Vital Signsby Bridgehead
Hansard to 12 November 2026 · 31,484 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Sector leader · Respiratory (asthma/COPD)
Houman Ashrafian, Ph.D.: no photograph is held, so the sector leader plate is shown instead.
Sector leader
Houman Ashrafian, Ph.D.
Executive Vice President, Head of Research and Development
Dec 2025Jan 2026FebMarAprMayJuneJulyAugSeptOctNovto date
1
Quoted in the press, across 1 topic since 7 Nov 2025
02 Quoted on · 1 of 29 topics
Houman Ashrafian, Ph.D.: key facts
- Kind of voice
- Sector leader
- Role
- Executive Vice President, Head of Research and Development
- Quoted on
- Respiratory (asthma/COPD)
- Press coverage
- Quoted in the press
- Most recently quoted
- 7 Apr 2026
- First quoted
- 7 Nov 2025
04 On the record · press
What Houman Ashrafian, Ph.D. has said
By outlet · bar length shows relative volume
- fiercebiotech.com
- sanofi.com
Where Houman Ashrafian, Ph.D. has been quoted
- Sanofi’s bispecific scores double respiratory phase 2 wins, but flunks eczema studyfiercebiotech.com · 7 Apr 2026
- Helping Patients Breathe Better: Addressing Unmet Needs in Respiratory Caresanofi.com · 7 Nov 2025
How we found the articles that name Houman Ashrafian, Ph.D.: we searched news for these terms.
- asthma
- COPD
- respiratory disease
- lung cancer screening
- pulmonary
Also searched with “asthma” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Respiratory (asthma/COPD)
Verbatim
“These data are promising and support our belief that the dual-targeting mechanism of lunsekimig may offer a novel treatment option for patients living with respiratory diseases, including asthma.”
“We need more options for people who do not respond to current treatments. It is not enough to say 'most' people respond. It will only be good enough when everyone has a functional treatment that works for them.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Asthma Salbutamol blue inhaler reminder as pharmacist issues messageWales Online
- UK pharmacist Salbutamol reminder for anyone taking blue inhaler for asthmaThe Mirror
- Fallowfield Grandad shares shock at being diagnosed with lung cancer despite having no symptoms – now he’s helping scientists look for cancer clues hidden in bloodAbout Manchester
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.